LJI scientists identify an autoimmune response that may help explain why Parkinson's disease is twice as prevalent in men.

Parkinson’s disease affects over 10 million people worldwide, with 60,000 new cases diagnosed annually in the U.S. Research ...

Millions of people worldwide are diagnosed and treated for Parkinson’s disease (PD). Unfortunately, in the U.S., there are about 1 million people wit | Immunology ...

Q4 2024 Earnings Conference Call February 26, 2025 4:30 PM ET. Company Participants. Katie Hogan - Senior Director-Corporate Communications and Investo ...

Advanced proteomic organ ageing is associated with the long-term risk of age-related diseases. In most cases, faster ageing ...

Scientists at La Jolla Institute for Immunology (LJI) have found a potential new target for treating Parkinson's disease.

The new research reveals how a protein in brain cells may drive Parkinson's onset -- and offers a possible explanation for why Parkinson's is much more common in men.

T here is still no cure for Parkinson’s disease, but the U.S. Food and Drug Administration (FDA) approved a new deep brain ...

People over the age of 60 are more susceptible to Parkinson's disease. As China's population continues to age, this new medical breakthrough has sparked hope within both the academic and medical ...

A breakthrough study has uncovered a hidden player in Parkinson’s disease—24-OHC, a cholesterol metabolite that fuels the ...

A comprehensive analysis has identified novel enhancers associated with neuronal development and disease.